X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Natco Pharma with SUVEN LIFE - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

NATCO PHARMA vs SUVEN LIFE - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    NATCO PHARMA SUVEN LIFE NATCO PHARMA/
SUVEN LIFE
 
P/E (TTM) x 34.7 16.5 210.0% View Chart
P/BV x 17.7 3.1 576.3% View Chart
Dividend Yield % 0.6 1.2 53.0%  

Financials

 NATCO PHARMA   SUVEN LIFE
EQUITY SHARE DATA
    NATCO PHARMA
Mar-14
SUVEN LIFE
Mar-16
NATCO PHARMA/
SUVEN LIFE
5-Yr Chart
Click to enlarge
High Rs877339 259.1%   
Low Rs424144 293.3%   
Sales per share (Unadj.) Rs223.439.2 569.3%  
Earnings per share (Unadj.) Rs31.17.5 416.4%  
Cash flow per share (Unadj.) Rs40.38.8 458.9%  
Dividends per share (Unadj.) Rs5.002.00 250.0%  
Dividend yield (eoy) %0.80.8 92.8%  
Book value per share (Unadj.) Rs219.549.0 448.0%  
Shares outstanding (eoy) m33.07127.28 26.0%   
Bonus/Rights/Conversions PA--  
Price / Sales ratio x2.96.2 47.3%   
Avg P/E ratio x20.932.4 64.7%  
P/CF ratio (eoy) x16.127.5 58.7%  
Price / Book Value ratio x3.04.9 60.1%  
Dividend payout %16.126.8 60.0%   
Avg Mkt Cap Rs m21,50430,732 70.0%   
No. of employees `000NA1.0 0.0%   
Total wages/salary Rs m1,128416 270.8%   
Avg. sales/employee Rs ThNM5,236.1-  
Avg. wages/employee Rs ThNM436.5-  
Avg. net profit/employee Rs ThNM995.5-  
INCOME DATA
Net Sales Rs m7,3894,995 147.9%  
Other income Rs m167194 86.4%   
Total revenues Rs m7,5565,189 145.6%   
Gross profit Rs m1,7931,233 145.5%  
Depreciation Rs m304167 182.1%   
Interest Rs m36654 675.6%   
Profit before tax Rs m1,2901,205 107.1%   
Minority Interest Rs m460-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m309255 121.1%   
Profit after tax Rs m1,027950 108.2%  
Gross profit margin %24.324.7 98.4%  
Effective tax rate %23.921.2 113.1%   
Net profit margin %13.919.0 73.1%  
BALANCE SHEET DATA
Current assets Rs m3,6814,986 73.8%   
Current liabilities Rs m3,1231,042 299.6%   
Net working cap to sales %7.679.0 9.6%  
Current ratio x1.24.8 24.6%  
Inventory Days Days8961 146.7%  
Debtors Days Days5939 150.0%  
Net fixed assets Rs m7,6853,126 245.9%   
Share capital Rs m331127 259.8%   
"Free" reserves Rs m6,6703,717 179.4%   
Net worth Rs m7,2596,236 116.4%   
Long term debt Rs m955432 220.9%   
Total assets Rs m11,9578,079 148.0%  
Interest coverage x4.523.2 19.5%   
Debt to equity ratio x0.10.1 189.8%  
Sales to assets ratio x0.60.6 99.9%   
Return on assets %11.712.4 93.8%  
Return on equity %14.215.2 92.9%  
Return on capital %20.718.9 109.8%  
Exports to sales %39.487.5 45.0%   
Imports to sales %5.712.2 46.6%   
Exports (fob) Rs m2,9084,371 66.5%   
Imports (cif) Rs m421611 69.0%   
Fx inflow Rs m3,4454,666 73.8%   
Fx outflow Rs m703942 74.6%   
Net fx Rs m2,7433,724 73.6%   
CASH FLOW
From Operations Rs m1,440922 156.2%  
From Investments Rs m-1,089-619 175.9%  
From Financial Activity Rs m-353-698 50.5%  
Net Cashflow Rs m-1-396 0.4%  

Share Holding

Indian Promoters % 52.0 63.4 82.1%  
Foreign collaborators % 1.5 0.0 -  
Indian inst/Mut Fund % 7.8 0.0 -  
FIIs % 16.6 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 26.0 36.5 71.2%  
Shareholders   25,395 37,287 68.1%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare NATCO PHARMA With:   STERLING BIOTECH  SANOFI INDIA  ALEMBIC PHARMA  ORCHID PHARMA LTD  PFIZER  

Compare NATCO PHARMA With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Finishes on a Flat Note; Coal India Stock Rallies 4.2%(Closing)

Indian share markets finished some selling pressure in the final hour of trade to finish flat amid weak European markets.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

Demonetisation Barely Made Any Difference to Tax Collections(Vivek Kaul's Diary)

Aug 7, 2017

The data tells us quite a different story from the one the government is trying to project.

Proxy Plays: A Smart Way to Bet on 'Off Limits' Companies(The 5 Minute Wrapup)

Aug 4, 2017

The small-cap space is full of small players that are clear proxies to great growth stories and Indian megatrends.

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

7 Financial Gifts For Your Sister This Raksha Bandhan(Outside View)

Aug 7, 2017

Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

NATCO PHARMA SHARE PRICE


Aug 17, 2017 (Close)

TRACK NATCO PHARMA

  • Track your investment in NATCO PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

NATCO PHARMA - ELDER PHARMA COMPARISON

COMPARE NATCO PHARMA WITH

MARKET STATS